Loading: 100%
MAJESCO ENTERTAINMENT CO logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 4 (as per FY 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker COOLno data available
Financial year endsFY ends End of Octoberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17010203040
datesClosing price (adj.)
13.10.201726.81
11.10.201727.07
04.10.201726.71
27.09.201726.99
20.09.201725.69
13.09.201726.74
06.09.201726.44
30.08.201731.68
23.08.201726.16
16.08.201724.95
09.08.201720.66
02.08.201718.95
26.07.201720.51
19.07.201722.08
12.07.201725.24
05.07.201721.48
27.06.201725.23
20.06.201719.99
13.06.201716.96
06.06.201716.83
30.05.201717.68
23.05.201715.24
16.05.201711.87
09.05.201711.47
02.05.201711.07
25.04.201711.15
18.04.201713.56
11.04.201714.45
04.04.201715.40
28.03.201711.04
21.03.20178.29
14.03.20177.33
07.03.20176.21
28.02.20176.33
21.02.20176.42
14.02.20175.04
07.02.20175.00
31.01.20173.81
24.01.20173.45
17.01.20173.53
10.01.20173.54
03.01.20173.27
27.12.20163.37
19.12.20163.24
12.12.20164.15
05.12.20163.09
28.11.20163.24
21.11.20163.13
14.11.20163.28
07.11.20162.79
31.10.20163.58
24.10.20163.21
17.10.20163.19
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
26.81n/a
Market Capitalisation
in million USD
13n/a
Enterprise Value
in million USD
6n/a
Common Shares Outstanding
as per Oct 31, 2016
473,104n/a
Preferred Shares Outstanding
as per Oct 31, 2016
1,253,657n/a
Average Basic Shares Outstanding
TTM
2,096,022n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
PolarityTE Inc owns application platform to regenerative medicine & tissue engineering, as well as software applications used in diagnosis & treatment related to regenerative medicine. Its platform develops specialized tissue and downstream function.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 7n/a
Receivables 0n/a
Total Current Assets 7n/a
PP&E 0n/a
Total Assets 7n/a
Accounts Payable 1n/a
Current Debt 0n/a
Total Current Liabilities 2n/a
Long-Term Debt 0n/a
Total Liabilities 2n/a
Total Equity 6n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital -1n/a
Operating Cash Flow -2n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid -10n/a
Financing Cash Flow 0n/a
Total Change in Cash -2n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.43n/a
Other Ratios
Current Ratio 440.8%n/a
Liabilities to Equity Ratio 29.2%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
97
77
128
132
47
34
7
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-141
-114
-157
-178
-70
-57
-7
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
-44
-37
-29
-45
-23
-23
0
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-29
-20
-33
-39
-23
-19
-6
Selling, General & Administrative
-23
-17
-25
-30
-17
-16
-6
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-5
-3
-7
-8
-6
-2
0
Depreciation & Amortization
0
0
0
-1
0
-1
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-72
-57
-61
-84
-46
-42
-7
Non-Operating Income (Loss)
-1
-1
-1
-1
0
0
0
Interest Expense, net
-1
-1
-1
-1
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-73
-58
-63
-85
-46
-42
-7
Abnormal Gains (Losses)
-1
0
-4
1
-1
-3
-1
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-75
-58
-67
-84
-48
-45
-7
Income Tax (Expense) Benefit, net
1
2
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-74
-56
-68
-84
-48
-45
-7
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-74
-56
-68
-84
-48
-45
-7
Minority Interest
0
0
0
0
0
0
0
Net Income
-74
-56
-68
-84
-48
-45
-7
Preferred Dividends
0
0
0
0
0
0
-2
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-74
-56
-68
-84
-48
-45
-9
Remarks
restated on Jan 17, 2012 n/a
calculated values,
restated on Jan 14, 2013 n/a
calculated values,
restated on Jan 14, 2014 n/a
calculated values,
restated on Jan 14, 2014 n/a
calculated values,
restated on Jan 29, 2015 n/a
calculated values,
restated on Jan 29, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 96% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
8
14
18
13
7
17
Cash & Cash Equivalents
n/a
8
14
18
13
7
17
Short Term Investments
n/a
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
1
3
4
1
2
0
Accounts Receivable, Net
n/a
1
3
4
1
2
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
8
12
8
5
1
0
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
12
23
18
14
1
0
Prepaid Expenses
n/a
1
3
2
3
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
11
19
16
11
1
0
Total Current Assets
n/a
29
51
48
33
11
18
Property, Plant & Equipment, Net
n/a
1
1
1
1
0
0
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
4
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
0
0
1
0
0
0
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
1
0
0
0
Total Noncurrent Assets
n/a
1
1
2
4
0
0
Total Assets
n/a
30
52
49
38
11
18
Liabilities and owners' equity
Payables & Accruals
n/a
11 11375000
20 20313000
15 15490000
9 8994000
4 4427000
2 1686000
Accounts Payable
n/a
11 11375000
20 20313000
15 15490000
9 8994000
4 4427000
2 1686000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
6 5557000
1 1238000
0 0
2 1764000
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
1 945000
6 5642000
4 4471000
7 6838000
1 1478000
0 318000
Deferred Revenue
n/a
1 945000
6 5642000
4 4454000
7 6838000
0 21000
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 17000
0 0
1 1457000
0 318000
Total Current Liabilities
n/a
18 17877000
27 27193000
20 19961000
18 17596000
6 5905000
2 2004000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
0 144000
2 1949000
0 0
0 0
0 0
0 0
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 144000
2 1949000
0 0
0 0
0 0
0 0
Total Noncurrent Liabilities
n/a
0 144000
2 1949000
0 0
0 0
0 0
0 0
Total Liabilities
n/a
18 18021000
29 29142000
20 19961000
18 17596000
6 5905000
2 2004000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
11 10694000
Share Capital & Additional Paid-In Capital
n/a
115 114863000
119 119263000
121 120797000
124 124194000
125 125278000
128 128499000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-102 -102333000
-96 -95501000
-91 -90888000
-104 -103530000
-120 -119727000
-124 -123536000
Other Equity
n/a
-1 -522000
-1 -527000
-1 -572000
-1 -611000
0 0
0 0
Equity Before Minority Interest
n/a
12 12008000
23 23235000
29 29337000
20 20053000
6 5551000
16 15657000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
12 12008000
23 23235000
29 29337000
20 20053000
6 5551000
16 15657000
Total Liabilities & Equity
n/a
30 30029000
52 52377000
49 49298000
38 37649000
11 11456000
18 17661000
Remarks restated on n/a restated on Jan 17, 2012 n/a restated on Jan 14, 2013 n/a restated on Jan 14, 2014 n/a restated on Jan 29, 2015 n/a restated on Jan 29, 2016 n/a restated on Sep 1, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-7
-1
7
5
-13
-16
-4
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
14
7
7
18
7
11
0
Non-Cash Items
12
6
14
7
6
11
2
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-25
-15
-18
-23
-5
-10
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-7
-3
9
6
-5
-4
-2
Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
-1
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
-4
-1
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
0
0
-1
0
-4
-1
1
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
5
0
-4
-1
4
-2
11
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
9
0
2
0
0
0
0
Increase in Capital Stock
9
0
2
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
13
0
-2
-1
4
-2
11
Net Cash Before Disc. Operations and FX
6
-4
6
4
-5
-6
10
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
6
-4
6
4
-5
-6
10
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
6
-4
6
4
-5
-6
10
Remarks
restated on Jan 17, 2012 n/a
calculated values,
restated on Jan 14, 2013 n/a
calculated values,
restated on Jan 14, 2014 n/a
calculated values,
restated on Jan 14, 2014 n/a
calculated values,
restated on Jan 29, 2015 n/a
calculated values,
restated on Jan 29, 2016 n/a
calculated values,
restated on Dec 30, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo